Cardiac and hepatic siderosis in myelodysplastic syndrome, thalassemia and diverse causes of transfusion-dependent anemia: the TIMES study-Reference-Cited by-同舟云学术

Cardiac and hepatic siderosis in myelodysplastic syndrome, thalassemia and diverse causes of transfusion-dependent anemia: the TIMES study

Published:2019-05-31 Issue:3 Volume:3 Page:e224
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:

Author:

Ho P. Joy,Hiwase Devendra,Ramakrishna Raj,Viiala Nicholas,Solterbeck Ann,Traficante Robert,Zor Evren,Gervasio Othon L.,High Laura M.,Ross David M.,Bowden Donald K.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology

Reference57 articles.

1. Complications of thalassemia major and their treatment;Borgna-Pignatti;Expert Rev Hematol.,2011

2. Incidence and clinical complications of myelodysplastic syndromes among United States Medicare beneficiaries;Goldberg;J Clin Oncol.,2010

3. Elevated liver iron concentration is a marker of increased morbidity in patients with β-thalassemia intermedia;Musallam;Haematologica.,2011

4. Oral iron chelators;Cappellini;Annu Rev Med.,2009

5. Exjade( (deferasirox, ICL670) in the treatment of chronic iron overload associated with blood transfusion;Cappellini;Ther Clin Risk Manag.,2007

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Therapeutic Landscape in Lower Risk Myelodysplastic Syndromes;Current Treatment Options in Oncology;2023-03-25

2. Secondary Iron Overload and the Liver: A Comprehensive Review;Journal of Clinical and Translational Hepatology;2023-02-01

3. The Outcomes of Patients with Haemoglobin Disorders in Cyprus: A Joined Report of the Thalassaemia International Federation and the Nicosia and Paphos Thalassaemia Centres (State Health Services Organisation);Thalassemia Reports;2022-11-04

4. Use of Deferasirox Film-Coated Tablets in Pediatric Patients with Transfusion Dependent Thalassemia: A Single Center Experience;Biology;2022-02-05

5. Iron Toxicity and Chelation Therapy in Hematopoietic Stem Cell Transplant;Transplantation and Cellular Therapy;2021-05